Skip to main content
Erschienen in: Clinical Rheumatology 7/2013

01.07.2013 | Original Article

Risk factors for body composition abnormalities in systemic sclerosis

verfasst von: Thais F. Marighela, Patrícia de S. Genaro, Marcelo M. Pinheiro, Vera L. Szejnfeld, Cristiane Kayser

Erschienen in: Clinical Rheumatology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the body composition (BC), bone mineral density (BMD), and the food intake in women with systemic sclerosis (SSc) compared to a control group, in order to identify main risk factors for BC abnormalities in SSc. Sixty-one SSc women and 67 age- and gender-matched controls were included. Spine, femur, and total body BMD measurements were performed using dual-energy X-ray absorptiometry. BC measurements included total lean (LM), fat mass (FM), and relative skeletal muscle mass index (RSMI) assessment. The food intake was calculated from 3-day food records and transformed into energy and nutrients. The 61 SSc patients [30 with diffuse cutaneous disease (dcSSc) and 31 with limited cutaneous SSc (lcSSc)] had significantly lower body mass index (BMI), LM, and FM, as well as lower BMD values compared to controls. Besides, the group with dcSSc, but not those with lcSSc, showed significantly lower BC and BMD measurements than controls. There was a significant inverse correlation between disease duration and BMI, LM, and RSMI. The total energy, macronutrients, and essential amino acids intakes were similar between patients and controls. After multivariate analysis, longer disease duration was the only risk factor associated with sarcopenia (RSMI below 5.45 kg/m2; OR = 1.36, 95 % CI 1.07–1.7). The present study showed an abnormal BC and a lower BMD, especially in dcSSc women, regardless of current food intake. Longer disease duration was associated with a higher risk of sarcopenia in SSc patients.
Literatur
1.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
2.
Zurück zum Zitat Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatol Suppl 48:iii3–iii7CrossRef Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatol Suppl 48:iii3–iii7CrossRef
3.
Zurück zum Zitat Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef
4.
5.
Zurück zum Zitat Rose S, Young MA, Reynolds JC (1998) Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 27:563–594PubMedCrossRef Rose S, Young MA, Reynolds JC (1998) Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 27:563–594PubMedCrossRef
6.
Zurück zum Zitat Brown M, Teubner A, Shaffer J, Herrick AL (2008) Home parenteral nutrition–an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatol 47:176–179CrossRef Brown M, Teubner A, Shaffer J, Herrick AL (2008) Home parenteral nutrition–an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatol 47:176–179CrossRef
7.
Zurück zum Zitat Lundberg AC, Akesson A, Akesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 51:1143–1148PubMedCrossRef Lundberg AC, Akesson A, Akesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 51:1143–1148PubMedCrossRef
8.
Zurück zum Zitat Baron M, Hudson M, Steele R (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36:1–6CrossRef Baron M, Hudson M, Steele R (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36:1–6CrossRef
9.
Zurück zum Zitat Krause L, Becker MO, Brueckner CS et al (2010) Nutritional status as marker for marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957PubMedCrossRef Krause L, Becker MO, Brueckner CS et al (2010) Nutritional status as marker for marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957PubMedCrossRef
10.
Zurück zum Zitat Souza RBC, Borges CTL, Takayama L, Aldrighi JM, Pereira RMR (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387PubMedCrossRef Souza RBC, Borges CTL, Takayama L, Aldrighi JM, Pereira RMR (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387PubMedCrossRef
11.
Zurück zum Zitat Woodrow G (2009) Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metb Care 12:8–14CrossRef Woodrow G (2009) Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metb Care 12:8–14CrossRef
12.
Zurück zum Zitat Lukaski HC (1987) Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 46:537–556PubMed Lukaski HC (1987) Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 46:537–556PubMed
13.
Zurück zum Zitat Mazess RB, Barden HS, Bisek JP, Hanson J (1990) Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106–1112PubMed Mazess RB, Barden HS, Bisek JP, Hanson J (1990) Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106–1112PubMed
14.
Zurück zum Zitat Haarbo J, Gotfredsen A, Hassager C, Christiansen C (1991) Validation of body composition by dual-energy x-ray absorptiometry (DEXA). Clin Physiol 11:331–341PubMedCrossRef Haarbo J, Gotfredsen A, Hassager C, Christiansen C (1991) Validation of body composition by dual-energy x-ray absorptiometry (DEXA). Clin Physiol 11:331–341PubMedCrossRef
15.
Zurück zum Zitat Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
16.
Zurück zum Zitat Clements PJ, Lachenbruch PA, Seibold JR et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892–1896PubMed Clements PJ, Lachenbruch PA, Seibold JR et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892–1896PubMed
17.
Zurück zum Zitat Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763PubMedCrossRef Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763PubMedCrossRef
18.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Jonsson B, DeLaet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590PubMedCrossRef Kanis JA, Johnell O, Oden A, Jonsson B, DeLaet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590PubMedCrossRef
19.
Zurück zum Zitat Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkarf HJ (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121PubMedCrossRef Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkarf HJ (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121PubMedCrossRef
20.
Zurück zum Zitat World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report Geneva (WHO) Technical report series 854 World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report Geneva (WHO) Technical report series 854
21.
Zurück zum Zitat Kolar AS, Patterson RE, White E et al (2005) A practical method for collection 3-day food records in a large cohort. Epidemiology 16:579–583PubMedCrossRef Kolar AS, Patterson RE, White E et al (2005) A practical method for collection 3-day food records in a large cohort. Epidemiology 16:579–583PubMedCrossRef
22.
Zurück zum Zitat Willet WC, Stampfer M (1998) Implications of total energy intake for epidemiological analyses. In: Willet W (ed) Nutritional epidemiology. Oxford University Press, New York, pp 273–301CrossRef Willet WC, Stampfer M (1998) Implications of total energy intake for epidemiological analyses. In: Willet W (ed) Nutritional epidemiology. Oxford University Press, New York, pp 273–301CrossRef
23.
Zurück zum Zitat Marshall A, Baumann A (2001) The international physical activity questionnaire summary report of the reliability and validity studies. Document of IPAQ Executive Committee, World Health Organization, Geneva Marshall A, Baumann A (2001) The international physical activity questionnaire summary report of the reliability and validity studies. Document of IPAQ Executive Committee, World Health Organization, Geneva
24.
Zurück zum Zitat Khanna D, Ahmed M, Furst DE et al (2007) Health values of patients with systemic sclerosis. Arthritis Care Res 57:86–93CrossRef Khanna D, Ahmed M, Furst DE et al (2007) Health values of patients with systemic sclerosis. Arthritis Care Res 57:86–93CrossRef
25.
Zurück zum Zitat Soeters PB, Schols AMWJ (2009) Advances in understanding and assessing malnutrition. Curr Opin Clin Nutr Metab Care 12:487–494PubMedCrossRef Soeters PB, Schols AMWJ (2009) Advances in understanding and assessing malnutrition. Curr Opin Clin Nutr Metab Care 12:487–494PubMedCrossRef
26.
Zurück zum Zitat Muscaritoli M, Anker SD, Argilés J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29:154–159PubMedCrossRef Muscaritoli M, Anker SD, Argilés J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29:154–159PubMedCrossRef
27.
Zurück zum Zitat Summers GD, Deighton CM, Rennie MJ, Booth AH (2008) Rheumatoid cachexia: a clinical perspective. Rheumatol 47:1124–1131CrossRef Summers GD, Deighton CM, Rennie MJ, Booth AH (2008) Rheumatoid cachexia: a clinical perspective. Rheumatol 47:1124–1131CrossRef
28.
Zurück zum Zitat Evans WJ, Morley JE, Argiles J et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799PubMedCrossRef Evans WJ, Morley JE, Argiles J et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799PubMedCrossRef
29.
Zurück zum Zitat Walker UA, Tyndall A, Czirjak L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 66:754–763PubMedCrossRef Walker UA, Tyndall A, Czirjak L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 66:754–763PubMedCrossRef
30.
Zurück zum Zitat Scala E, Pallotta S, Frezzolini A et al (2004) Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 138:540–546PubMedCrossRef Scala E, Pallotta S, Frezzolini A et al (2004) Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 138:540–546PubMedCrossRef
31.
Zurück zum Zitat Gómez R, Conde J, Scotece M et al (2011) What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7:528–536PubMedCrossRef Gómez R, Conde J, Scotece M et al (2011) What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7:528–536PubMedCrossRef
32.
Zurück zum Zitat Morley JE (2013) Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 16:27–32PubMedCrossRef Morley JE (2013) Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 16:27–32PubMedCrossRef
33.
Zurück zum Zitat Lakota K, Wei J, Carns M et al (2012) Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 14:R102PubMedCrossRef Lakota K, Wei J, Carns M et al (2012) Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 14:R102PubMedCrossRef
34.
Zurück zum Zitat La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 10:18–22PubMedCrossRef La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 10:18–22PubMedCrossRef
35.
Zurück zum Zitat Di Munno O, Mazzantini M, Massei P et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407–412PubMedCrossRef Di Munno O, Mazzantini M, Massei P et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407–412PubMedCrossRef
36.
Zurück zum Zitat Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23:180–184PubMed Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23:180–184PubMed
37.
Zurück zum Zitat Food and Nutrition Board, Institute of Medicine of the National Academies (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). National Academy Press, Washington, DC Food and Nutrition Board, Institute of Medicine of the National Academies (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). National Academy Press, Washington, DC
38.
Zurück zum Zitat Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA (2009) Nutrient intakes related to osteoporotic fractures in men and women—the Brazilian osteoporosis Study (BRAZOS). Nutr J 8:6PubMedCrossRef Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA (2009) Nutrient intakes related to osteoporotic fractures in men and women—the Brazilian osteoporosis Study (BRAZOS). Nutr J 8:6PubMedCrossRef
39.
Zurück zum Zitat Ma Y, Hebert HR, Li W et al (2008) Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 24:941–949PubMedCrossRef Ma Y, Hebert HR, Li W et al (2008) Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 24:941–949PubMedCrossRef
Metadaten
Titel
Risk factors for body composition abnormalities in systemic sclerosis
verfasst von
Thais F. Marighela
Patrícia de S. Genaro
Marcelo M. Pinheiro
Vera L. Szejnfeld
Cristiane Kayser
Publikationsdatum
01.07.2013
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 7/2013
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2235-1

Weitere Artikel der Ausgabe 7/2013

Clinical Rheumatology 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.